Cargando…
Human iPSC-Derived Neural Crest Stem Cells Exhibit Low Immunogenicity
Recent clinical trials are evaluating induced pluripotent stem cells (iPSCs) as a cellular therapy in the field of regenerative medicine. The widespread clinical utility of iPSCs is expected to be realized using allogeneic cells that have undergone thorough safety evaluations, including assessment o...
Autores principales: | Mehler, Vera J., Burns, Chris J., Stauss, Hans, Francis, Robert J., Moore, Melanie L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005462/ https://www.ncbi.nlm.nih.gov/pubmed/32055644 http://dx.doi.org/10.1016/j.omtm.2019.12.015 |
Ejemplares similares
-
Cells derived from iPSC can be immunogenic — Yes or No?
por: Cao, Jiani, et al.
Publicado: (2014) -
Immunogenicity and functional evaluation of iPSC-derived organs for transplantation
por: Wang, Libin, et al.
Publicado: (2015) -
Nucleosome dynamics of human iPSC during neural differentiation
por: Harwood, Janet C, et al.
Publicado: (2019) -
iPSC-derived cranial neural crest-like cells can replicate dental pulp tissue with the aid of angiogenic hydrogel()
por: Kobayashi, Yoshifumi, et al.
Publicado: (2021) -
Low Immunogenicity and Immunosuppressive Properties of Human ESC- and iPSC-Derived Retinas
por: Yamasaki, Suguru, et al.
Publicado: (2021)